A melanocortin-receptor agonist that acts on brain pathways involved in sexual desire, not the blood-flow pathway targeted by Viagra and Cialis.
Starting at $199/mo Start Assessment →
Get started in 3 simple steps. No office visits required.
Answer a few health questions. Our board-certified physicians review your medical history and determine if PT-141 is right for you.
If approved, your prescription is sent to our partner pharmacy. Your medication is compounded fresh and shipped directly to your door.
Inject as needed at home. Track your progress with our app. Our care team is available 24/7 for support and dose adjustments.
Physician-prescribed therapy for sexual desire.
In phase 3 trials, FDA-approved bremelanotide significantly improved sexual desire and reduced related distress in premenopausal women with acquired, generalized HSDD.
Activates mc1r/mc3r/mc4r pathways
Inject as needed at home with guided support
Works through the central nervous system rather than the PDE-5 blood-flow pathway.
Phase 3 evidence for FDA-approved bremelanotide in premenopausal women with acquired, generalized HSDD.
Kingsberg et al., Obstetrics & Gynecology 2019. FDA-approved bremelanotide significantly improved sexual desire and reduced related distress versus placebo in premenopausal women with acquired, generalized HSDD.
Mechanism of Action
Activates mc1r/mc3r/mc4r pathways
Acts on melanocortin pathways involved in sexual desire.
Uses a different mechanism from Viagra and Cialis.
Bremelanotide acts on melanocortin pathways in the central nervous system rather than on blood flow. It is the active ingredient in an FDA-approved injectable therapy for certain women; this compounded formula is not FDA-approved.
Important information about PT-141 safety and side effects.
Everything you need to know about PT-141.
Your assessment takes about 5 minutes. A licensed provider takes it from there.
Start Assessment →NAD+ is a coenzyme involved in cellular energy pathways.
Glutathione is a tripeptide antioxidant involved in redox balance and detoxification pathways.